{"disease":{"id":"safety-and-efficacy","name":"safety and efficacy"},"drugs":{"marketed":[],"pipeline":[{"drug_id":"chlorthalidone","indication_name":"Safety and efficacy of chlorthalidone in type 1 diabetes","indication_type":"pipeline","phase":"Phase 2","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"CHLORTHALIDONE","company_name":"","drug_phase":"marketed","molecular_target":"Na+/Cl− cotransporter","drug_class":"Thiazide-like Diuretic [EPC]","quality_score":10,"revenue":null,"mechanism":""}],"offLabel":[],"totalMarketed":0,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT04852068","title":"A Clinical Trial of Freeze-dried Human Rabies Vaccine (Vero Cells)","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":2480,"lead_sponsor_name":"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.","has_results":false},{"nct_id":"NCT04577040","title":"Safety and Efficacy of Tadalafil vs. Tadalafil With Sildosin in the Management of Moderately and Severely Symptomatic Patients of Prostatic Hyperplasia","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Menoufia University","has_results":false},{"nct_id":"NCT04621123","title":"Plasma for Early Treatment in Non-hospitalised Mild or Moderate COVID-19 Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":384,"lead_sponsor_name":"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia","has_results":false},{"nct_id":"NCT05556889","title":"Safety and Analgesic Efficacy of a Modified Auriculotemporal Nerve Block","phase":"NA","overall_status":"RECRUITING","enrollment_count":252,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT04550637","title":"A Multi-center Study of Apixaban(APPROACH)","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT05349552","title":"Safety and Efficacy of SBRT in the Treatment of Thoracic Malignant Tumors at Different Sites","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT03869164","title":"Multi-center Trial of ValveClamp","phase":"NA","overall_status":"UNKNOWN","enrollment_count":110,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT04195997","title":"Multi-center Application of Bivalirudin in Left Atrial Appendage Occlusion","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT04446806","title":"Prevention and Treatment of Differentiation Syndrome in Patients With Acute Promyelocytic Leukemia","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT04205201","title":"The Effectiveness of Topical Latanoprost Compared With Topical Brimonidine in the Treatment of the Primary Open Angle Glaucoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Chittagong Medical College","has_results":false},{"nct_id":"NCT05021276","title":"Basiliximab Combined With Ruxolitinib as Second-line Treatment of Grade 3-4 Steroid-resistant aGVHD","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT03637933","title":"Endoscopic Tattooing and Colorectal Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Federico II University","has_results":false},{"nct_id":"NCT05256823","title":"Safety and Efficacy of Celecoxib Plus Nucleos(t)Ide Analogues on the Hepatitis B Surface Antigen of Virally Suppressed Subjects With Chronic Hepatitis B","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":47,"lead_sponsor_name":"Lai Wei","has_results":false},{"nct_id":"NCT06066840","title":"Vedolizumab, Anti-CD25 Antibody, Rapid Reduction of Glucocorticoids for SR-aGVHD With Gastrointestinal Involvement","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":45,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT03820596","title":"Sintilimab in Combination With Chidamide in Refractory and Relapsed ENKTCL","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Huiqiang Huang","has_results":false},{"nct_id":"NCT05008666","title":"Induction Chemotherapy Sequential Sintilimab Combined With Dual Epigenetic Drugs for ENKTL-HLH","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":37,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT04994210","title":"Sintilimab in Combination With Chidamide in Newly Diagnosed ENKTCL","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT03164928","title":"Safety and Efficiency of Denosumab in Pediatric Subjects With Glucocorticoid-induced Osteoporosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT04166838","title":"The Clinical Study of CD19 UCAR-T Cells in Patients With B-cell Acute Lymphoblastic Leukemia (B-ALL)","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Shanghai Longyao Biotechnology Inc., Ltd.","has_results":false},{"nct_id":"NCT06244537","title":"Study on the Safety and Efficacy of MR-Linac Technique in Patients With Unresectable Locally Advanced Colon Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Sichuan Cancer Hospital and Research Institute","has_results":false},{"nct_id":"NCT05140616","title":"Study of Chidamide for Steroid-resistant/Steroid-dependent Severe cGVHD","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT04785170","title":"Clinical Study to Evaluate Safety and Efficacy of Amino Acid in Healthy Individuals","phase":"NA","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"Vedic Lifesciences Pvt. Ltd.","has_results":false},{"nct_id":"NCT06572956","title":"Clinical Study on the Safety and Efficacy of CAR-T/CAR-NK Cells in the Treatment of Recurrent Refractory or Unresectable Solid Tumors","phase":"EARLY_PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":10,"lead_sponsor_name":"The Second Hospital of Shandong University","has_results":false},{"nct_id":"NCT05963100","title":"Clinical Study of TCR-like CAR-T Cell Targeted MSLN in the Treatment of Ovarian Cancer","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":10,"lead_sponsor_name":"Zhongda Hospital","has_results":false},{"nct_id":"NCT05247957","title":"NKG2D CAR-NK Cell Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia","phase":"NA","overall_status":"TERMINATED","enrollment_count":9,"lead_sponsor_name":"Hangzhou Cheetah Cell Therapeutics Co., Ltd","has_results":false},{"nct_id":"NCT07085195","title":"A Clinical Study of the Safety and Efficacy of Chemogenetics Therapy in the Treatment of Parkinson's Disease","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":6,"lead_sponsor_name":"Ruijin Hospital","has_results":false}],"total":26},"guidelines":[],"source":"Drug Landscape verified database"}